日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Bidirectional Interaction Between Liposomal Amphotericin B Pharmacokinetics and Parasite Dynamics in Patients With Post-Kala-Azar Dermal Leishmaniasis: Potential Implications for Optimal Dosing

脂质体两性霉素B药代动力学与黑热病后皮肤利什曼病患者寄生虫动力学之间的双向相互作用：对最佳剂量方案的潜在影响

期刊:Clinical Pharmacology & Therapeutics
影响因子:5.5
doi:10.1002/cpt.70124
Chu, Wan-Yu; Singh, Om Prakash; Sundar, Shyam; Mondal, Dinesh; Pandey, Krishna; Das, Pradeep; Roseboom, Ignace C; Raja, Sheeraz; Torres, Ana; Carrillo, Eugenia; Huitema, Alwin D R; Alves, Fabiana; Dorlo, Thomas P C
微生物学
发表日期：2026
文献求助 收藏

Translational Pharmacokinetic-Pharmacodynamic Modeling and Efficacious Human Dose Prediction of DNDI-6148 for the Treatment of Cutaneous Leishmaniasis

DNDI-6148治疗皮肤利什曼病的转化药代动力学-药效学模型及有效人体剂量预测

期刊:Cts-Clinical and Translational Science
影响因子:2.8
doi:10.1111/cts.70535
Henninger, Rasmus Hansen; Schouten, Wietse M; Arana, Byron; Gillon, Jean-Yves; Mowbray, Charles E; Kratz, Jadel Müller; Van Bocxlaer, Katrien; Dorlo, Thomas P C
Human
发表日期：2026
文献求助 收藏

Does one model fit all mAbs? An evaluation of population pharmacokinetic models

一种模型是否适用于所有单克隆抗体？群体药代动力学模型的评估

期刊:MAbs
影响因子:7.3
doi:10.1080/19420862.2025.2512217
van den Berg, Stefan P H; Adolfsen, Philine E A; Dorlo, Thomas P C; Rispens, Theo
单克隆抗体
发表日期：2025
文献求助 收藏

Pharmacokinetics and Pharmacodynamics of Fosravuconazole, Itraconazole, and Hydroxyitraconazole in Sudanese Patients With Eumycetoma

福沙康唑、伊曲康唑和羟基伊曲康唑在苏丹真菌性足菌肿患者中的药代动力学和药效学研究

期刊:Journal of Infectious Diseases
影响因子:4.5
doi:10.1093/infdis/jiaf279
Chu, Wan-Yu; Fahal, Ahmed H; Ahmed, Eiman Siddig; Bakhiet, Sahar Mubarak; Bakhiet, Osama Elhadi; Fahal, Lamis Ahmed; Mohamed, Abubakar Ahmed; Mohamedelamin, El Sammani Wadaa; Bahar, Mustafa El Nour; Attalla, Hadil Yassir; Siddig, Emmanuel Edwar; Mhmoud, Najwa A; Musa, Ahmed Mudawi; Oyieko, Peelen; Egondi, Thaddaeus; Brüggemann, Roger J; Hata, Katsura; Strub-Wourgaft, Nathalie; Alves, Fabiana; Nyaoke, Borna A; Zijlstra, Eduard E; Dorlo, Thomas P C
微生物学
发表日期：2025
文献求助 收藏

Importance of Lysosomal Trapping and Plasmodium Parasite Infection on the Pharmacokinetics of Pyronaridine: A Physiologically Based Pharmacokinetic Model-Based Study

溶酶体滞留和疟原虫感染对吡咯萘啶药代动力学的重要性：基于生理药代动力学模型的研究

期刊:Clinical Pharmacokinetics
影响因子:4
doi:10.1007/s40262-025-01581-6
Chu, Wan-Yu; Schouten, Wietse M; Mavoko, Hypolite Muhindo; Tshiongo, Japhet Kabalu; Yobi, Doudou Malekita; Kabasele, Freddy-Arnold; Kasereka, Gustave; Maketa, Vivi; Sevene, Esperança; Vala, Anifa; Shin, Jangsik; D'Alessandro, Umberto; Kayentao, Kassoum; Huitema, Alwin D R; Dorlo, Thomas P C
炎症/感染
发表日期：2025
文献求助 收藏

Pharmacokinetic Model-Informed Precision Dosing of Natalizumab in Multiple Sclerosis

基于药代动力学模型的纳他珠单抗精准给药治疗多发性硬化症

期刊:Cpt-Pharmacometrics & Systems Pharmacology
影响因子:3
doi:10.1002/psp4.70014
van den Berg, Stefan P H; Toorop, Alyssa A; Hooijberg, Femke; Wolbink, Gertjan; Voelkner, Nivea M F; Gelissen, Liza M Y; Killestein, Joep; van Kempen, Zoé L E; Dorlo, Thomas P C; Rispens, Theo
神经科学
多发性硬化症
发表日期：2025
文献求助 收藏

Disease-Specific Differences in Pharmacokinetics of Paromomycin and Miltefosine Between Post-Kala-Azar Dermal Leishmaniasis and Visceral Leishmaniasis Patients in Eastern Africa

东非黑热病后皮肤利什曼病患者和内脏利什曼病患者对巴龙霉素和米替福新药代动力学的疾病特异性差异

期刊:Journal of Infectious Diseases
影响因子:4.5
doi:10.1093/infdis/jiae413
Chu, Wan-Yu; Verrest, Luka; Younis, Brima M; Musa, Ahmed M; Mbui, Jane; Mohammed, Rezika; Olobo, Joseph; Ritmeijer, Koert; Monnerat, Séverine; Wasunna, Monique; Roseboom, Ignace C; Solomos, Alexandra; Huitema, Alwin D R; Alves, Fabiana; Dorlo, Thomas P C
发表日期：2024
文献求助 收藏

Determining tissue distribution of the oral antileishmanial agent miltefosine: a physiologically-based pharmacokinetic modeling approach

确定口服抗利什曼原虫药物米替福新在组织中的分布：一种基于生理学的药代动力学建模方法

期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/aac.00328-24
Ramisetty, Bhargavi Srija; Yang, Sihyung; Dorlo, Thomas P C; Wang, Michael Zhuo
发表日期：2024
文献求助 收藏

Population Pharmacokinetics and Target Attainment of Allopurinol and Oxypurinol Before, During, and After Cardiac Surgery with Cardiopulmonary Bypass in Neonates with Critical Congenital Heart Disease

新生儿危重先天性心脏病患者在体外循环心脏手术前、术中和术后别嘌醇和氧嘌醇的群体药代动力学及目标浓度达标情况

期刊:Clinical Pharmacokinetics
影响因子:4
doi:10.1007/s40262-024-01401-3
Chu, Wan-Yu; Nijman, Maaike; Stegeman, Raymond; Breur, Johannes M P J; Jansen, Nicolaas J G; Nijman, Joppe; van Loon, Kim; Koomen, Erik; Allegaert, Karel; Benders, Manon J N L; Dorlo, Thomas P C; Huitema, Alwin D R
心脏病
心血管
发表日期：2024
文献求助 收藏

Leishmania blood parasite dynamics during and after treatment of visceral leishmaniasis in Eastern Africa: A pharmacokinetic-pharmacodynamic model

东非内脏利什曼病治疗期间及治疗后利什曼原虫血液寄生虫动态：药代动力学-药效学模型

期刊:PLoS Neglected Tropical Diseases
影响因子:3.4
doi:10.1371/journal.pntd.0012078
Verrest, Luka; Monnerat, Séverine; Musa, Ahmed M; Mbui, Jane; Khalil, Eltahir A G; Olobo, Joseph; Wasunna, Monique; Chu, Wan-Yu; Huitema, Alwin D R; Schallig, Henk D F H; Alves, Fabiana; Dorlo, Thomas P C
微生物学
发表日期：2024
文献求助 收藏